How CBD Fights Seizures Through the Brain's Inflammation System

One of the challenges in understanding CBD's anti-seizure action is that it doesn't work through a single, clean mechanism the way most drugs do. This review maps the multiple pathways through which CBD appears to reduce seizures, with particular attention to neuroinflammation.

About one-third of epilepsy patients are resistant to conventional medications, many of which work through a single mechanism (usually enhancing GABA signaling). CBD's multi-target approach may explain why it helps some patients who don't respond to these drugs.

The neuroinflammation connection is especially interesting. Inflammation in the brain isn't just a consequence of seizures—it's now understood to be part of what causes them (epileptogenesis). CBD reduces neuroinflammation through immunomodulatory effects, potentially breaking the cycle where seizures cause inflammation which causes more seizures.

Beyond inflammation, CBD modulates the endocannabinoid system, adenosine receptors (involved in neural excitability), GPR55 receptors (recently linked to seizure activity), and TRPV1 channels (which regulate calcium signaling in neurons). It also reduces oxidative stress, which damages neurons and contributes to seizure susceptibility.

The FDA approved purified CBD (Epidiolex) in 2018 for Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. This review provides the mechanistic foundation for understanding why it works and why it might work for other neurological conditions too.